Search By:
Adult Trials: Let us know you're interested by sending an email, chatting online or calling 864-334-0141
Type II Diabetes Treatment
A study for patients with Type II Diabetes to evaluate the safety and effectiveness of an investigational medication compared with conventional care in adults. The study drug is an injectable medication.
Study ID: I8H-MC-GPHE
A study for patients with Type II Diabetes to evaluate the safety and effectiveness of an investigational medication compared with conventional care in adults. The study drug is an injectable medication.
Download PDFMigraine Prevention Oral Medication
A study for patients with moderate to severe migraine headaches. This study is to evaluate the safety and efficacy of an already FDA approved migraine treatment medication, for preventative treatment of episodic migraines in adults.
Study ID: BHV3000-404
A study for patients with moderate to severe migraine headaches. This study is to evaluate the safety and efficacy of an already FDA approved migraine treatment medication, for preventative treatment of episodic migraines in adults.
Type II Diabetes Treatment
A study for patients with Type II Diabetes to evaluate the safety and effectiveness of an investigational medication compared with conventional care in adults. The study drug is an injectable medication.
Study ID: I8H-MC-GPIL
A study for patients with Type II Diabetes to evaluate the safety and effectiveness of an investigational medication compared with conventional care in adults. The study drug is an injectable medication.
Weight Loss
A study to evaluate the safety and efficacy of an investigational once weekly injection compared to placebo, in participants with severe obesity and established cardiovascular disease.
Study ID: J1I-MC-GZBM
A study to evaluate the safety and efficacy of an investigational once weekly injection compared to placebo, in participants with severe obesity and established cardiovascular disease.
Pediatric Trials: Let us know you're interested by sending an email, chatting online or calling 864-334-0141
Migraine Prevention
A study for patients 6 to less than 18 years old for a migraine prevention medication. This study is to evaluate the safety and efficacy of a medication used to prevent migraine headaches. The study medication is FDA approved for treatment and prevention of migraine headaches in adults patients.
Study ID: BHV3000-315
A study for patients 6 to less than 18 years old for a migraine prevention medication. This study is to evaluate the safety and efficacy of a medication used to prevent migraine headaches. The study medication is FDA approved for treatment and prevention of migraine headaches in adults patients.
Migraine Treatment
A study for pediatric patients, ages 11-17 with migraine headaches. This study is to evaluate an oral disintegrating tablet in children and teens compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment and prevention of migraines in adult patients.
Study ID: BHV3000-311
A study for pediatric patients, ages 11-17 with migraine headaches. This study is to evaluate an oral disintegrating tablet in children and teens compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment and prevention of migraines in adult patients.
Download PDFMigraine Treatment
A study for pediatric patients, ages 6-17, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.
Study ID: Abbvie 3110-305
A study for pediatric patients, ages 6-17, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.
Download PDFMigraine Treatment
A study for pediatric patients, ages 6 to less than 18, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.
Study ID: LAHV
A study for pediatric patients, ages 6 to less than 18, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.
Download PDFFussy Baby Infant Formula
A formula study for infants 2 weeks to 2 months who are fussy on regular cow’s milk-based formula. This study is to evaluate the study formula to see if it improves fussiness.
Study ID: MJN3392
A formula study for infants 2 weeks to 2 months who are fussy on regular cow’s milk-based formula. This study is to evaluate the study formula to see if it improves fussiness.
Download PDFNutritional Supplement
A study to evaluate the effects of oral nutritional supplementation with dietary counseling in children at risk of undernutrition.
Study ID: AL48
A study to evaluate the effects of oral nutritional supplementation with dietary counseling in children at risk of undernutrition.
Infant Probiotic
A study for infants less than 14 days old at risk for developing allergic disease including atopic dermatitis, food allergy, asthma and allergic rhinitis. This study is to evaluate the safety and effectiveness of an oral powder that will be mixed with breastmilk or formula.
Study ID: STMC-103H-102
A study for infants less than 14 days old at risk for developing allergic disease including atopic dermatitis, food allergy, asthma and allergic rhinitis. This study is to evaluate the safety and effectiveness of an oral powder that will be mixed with breastmilk or formula.
Download PDFCovid-19 Vaccine
A study for patients 6 to less than 12 years of age for a Covid-19 vaccine. This study is to evaluate the safety and immune response of an investigational vaccine that might protect against Covid-19.
Study ID: Novavax 2019nCoV-503
A study for patients 6 to less than 12 years of age for a Covid-19 vaccine. This study is to evaluate the safety and immune response of an investigational vaccine that might protect against Covid-19.
Download PDFPneumococcal Vaccine
A study for infants 2 months of age. This study is to evaluate the safety and efficacy of a 24 valent pneumococcal vaccine.
Study ID: VAX24-112
A study for infants 2 months of age. This study is to evaluate the safety and efficacy of a 24 valent pneumococcal vaccine.
Migraine Prevention
A study for patients 6 to less than 18 years old for a migraine prevention medication. This study is to evaluate the safety and efficacy of a medication used to prevent migraine headaches. The study medication is FDA approved for treatment and prevention of migraine headaches in adults patients. This medication is an injectable.
Study ID: I8Q-MC-CGAS
A study for patients 6 to less than 18 years old for a migraine prevention medication. This study is to evaluate the safety and efficacy of a medication used to prevent migraine headaches. The study medication is FDA approved for treatment and prevention of migraine headaches in adults patients. This medication is an injectable.